01810nas a2200337   4500000000100000008004100001260001700042653001500059653001000074653001600084653001200100653003000112653001100142653001100153653001800164653001200182653001500194653000900209653001400218653001300232100001900245700001300264700001600277700001500293700001500308245012000323300001100443490000700454520099700461022001401458       1978                            d  c1978 May-Jun10aAdolescent10aAdult10aBCG Vaccine10aDapsone10aDrug Therapy, Combination10aFemale10aHumans10aImmunotherapy10aleprosy10aLevamisole10aMale10aNeisseria10aRifampin1 aSaint-André P1 aLouvet M1 aGiraudeau P1 aDiscamps G1 aSchlecht B00a[Present evaluation of hansenian treatment by association of chemotherapy and immunostimulation (author's transl)].  a331-490 v383 a<p>I.--Treatment with BCG and DDS in lepromatous or borderline patients. II.--Value of BCG added to a prior and long-continued treatment with DDS or rifamipicine. III.--Value of various immunostimulants given previously to a treatment with BCG and chemotherapy. IV.--Value of lysate of Neisseria perflava as an immunostimulant associated with DDS in an initial treatment of lepromatous and borderline patients. V.--Results of a seventeen months treatment of lepromatous and borderline patients with a lysate of Neisseria perflava associated with DDS. The various therapeutic trials reported in these 5 papers demonstrate that hansenian nevritis conventionnally treated may show improvement when an immunostimulant (BCG or bacterial lysate or levamisole) is given either previously or in association with DDS or rifampicine or after such a treatment. It has still been observed that two immunostimulants given simultaneously have no good effect and that this association must be discarded.</p>  a0025-682X